Participation à des colloques
Liste des communications à des congrès
Networking 2016-2024
20 Communications écrites dont 7 internationales
“The specific optical properties of foamy macrophage (Mf) may be due to their lipid handling leading to ceroid accumulation.” Henni Mansour A.S., Ragues M., Borowczyk C., Grevelinger J., Laroche-Traineau J., Brevier J., Garaude J., Marais S., Jacobin-Valat M.-J., Gerbaud E., Clofent-Sanchez G., and Ottones F. Lyon, France, 92nd EAS virtual Congress, May 26-29, 2024.
“Atherosclerosis and adverse pregnancy outcomes: common biomarkers involved”. Ragues M., Mohamad S., Panchenko P., Crampes C., Curot P., Claverol S., Marais S., Ottones F., Clofent-Sanchez G., El Hajj Dib I., Jacobin-Valat M.J. Lyon, France, 92nd EAS virtual Congress, May 26-29, 2024.
“Modulation of the nanoparticles “Protein Corona” by tailoring their surface chemistry”. Coste H., Ottones F., Clofent-Sanchez G., Raymond A-A., Boudier A. and Mornet S. SFNano, Montpellier, December 2023.
“Neonatal hypoxia-ischemia and neuroprotection of lactate: impact on the microglia phenotypic and metabolic switches: Omar I., Frezals J., Guichard C., Ottones F., Pellerin L., Roumes H, Laroche-Traineau J. and Bouzier-Sore A-K. Young Glial Cell Club, Lyon, May 23, 2023.
“Characterization of different experimental models of foamy macrophages: towards new strategies for the development of targeted diagnostic and therapy for Atherosclerosis”. Henni Mansour A.S., Ragues M., Grevelinger J., Borowczyk C., Laroche-Traineau J., Brevier J., Garaude J., Marais S., Gerbaud E., Jacobin-Valat M-J., Clofent-Sanchez G., and Ottones F. NSFA, Biarritz, June 21-23, 2023. Sélectionné pour une presentation orale pour le prix poster.
“Distinct functional phenotypes between major models of foamy macrophages: consequences and impact in the field of therapeutic research”. Brévier J., Gerbaud E., Borowczyk C., Grevelinger J., Laroche-Traineau J., Marais S, Jacobin-Valat M-J., Clofent-Sanchez G. and Ottones F. NSFA, Biarritz, June 22-24, 2022.
“The specific optical properties of foamy macrophages may be due to their specific metabolism and/or lipid handling”. Borowczyk C., Laroche-Traineau J., Grevelinger J., Brevier J., Garaude J., Marais, S. Gerbaud E., Jacobin-Valat M.-J., Clofent-Sanchez G., and Ottones F. NSFA, Biarritz, June 22-24, 2022.
“Distinct functional phenotypes between major models of foamy macrophages: consequences and impact in the field of therapeutic research”. Brévier J, Gerbaud E., Borowczyk C., Grevelinger J., Laroche-Traineau J, Marais S., Jacobin-Valat M-J., Clofent-Sanchez G. and Ottones F. Milan, Italy, 90th EAS virtual Congress, May 22-25, 2022.
“Distinct functional phenotypes between major models of foamy macrophages: consequences and impact in the field of therapeutic research”. Brévier J., Gerbaud E., Borowczyk C., Grevelinger J., Laroche-Traineau J., Marais S, Jacobin-Valat M-J., Clofent-Sanchez G. and Ottones F. 4th Symposium of the Occitanie network on Monocytes-Macrophages (SoMM2021), Bordeaux, November 26, 2021.
“The specific optical properties of foamy macrophages may be due to their specific metabolism and/or lipid handling”. Borowczyk C., Laroche-Traineau J., Grevelinger J., Brevier J., Garaude J., Marais, S. Gerbaud E., Jacobin-Valat M.-J., Clofent-Sanchez G., and Ottones F. 4th Symposium of the Occitanie network on Monocytes-Macrophages (SoMM2021), Bordeaux, November 26, 2021.
“The specific optical properties of foamy macrophages may be due to their specific metabolism and/or lipid handling”. Borowczyk C., Laroche-Traineau J., Grevelinger J., Rossignol A., Jacobin-Valat M-J., Clofent-Sanchez G.and Ottones F. 89th EAS virtual Congress, May 30-June 02, 2021.
“Autofluorescent intracellular NADH and FAD may be used to detect atheromatous plaque macrophages: a new tool to characterize phage-display selected human antibodies”. Borowczyk C., Laroche-Traineau J., Brevier J., Marais S., Gerbaud E., Clofent-Sanchez G., and Ottones F. 3rd Symposium of the Occitanie network on Monocytes-Macrophages (SoMM2019), Montpellier, November 29, 2019.
“Autofluorescent intracellular NADH and FAD may be used to detect atheromatous plaque macrophages: a new tool to characterize phage-display selected human antibodies”. Borowczyk C., Ottones F, Laroche Traineau J., Jacobin-Valat MJ., Clofent-Sanchez G. Club Anticorps, Paris, October 8, 2019.
“Autofluorescent intracellular NADH and FAD may be used to detect atheromatous plaque macrophages”. Borowczyk C., Laroche-Traineau J., Brevier J., Marais S., Gerbaud E., Clofent-Sanchez G., and Ottones F. 7th Antibody Industrial Symposium 2019 (AIS2019), June 24-25, 2019.
“Autofluorescent intracellular NADH and FAD may be used to detect atheromatous plaque”. Borowczyk C., Laroche-Traineau J., Brevier J., Marais S., Gerbaud E., Clofent-Sanchez G., and Ottones F. 87th EAS Congress. Maastricht, May 26-29, 2019.
“Autofluorescent intracellular NADH and FAD may be used to detect atheromatous plaque”. Borowczyk C., Laroche-Traineau J., Brévier J., Marais S., Gerbaud E., Clofent-Sanchez G. and Ottones F. EAS satellite immunometabolism. Interplay of Metabolism, Inflammation and Vascular Biology. Maastricht, May 25-26, 2019.
“Potential of autofluorescent intracellular NADH and FAD to be used as biomarkers of the vulnerability of the atheromatous plaques”. Borowczyk C., Laroche-Traineau J., Gerbaud E., Ottones F., and Clofent-Sanchez G. 2nd Symposium of the Occitanie network on Monocytes-Macrophages (SoMM2018), Toulouse, November 30, 2018.
“Potential of autofluorescent intracellular NADH and FAD to be used as biomarkers of the vulnerability of the atheromatous plaques”. Brevier J., Lion R., Borowczyk C., Laroche-Traineau J., Ottones F., Clofent-Sanchez G., and Gerbaud E. NSFA, Biarritz, June 20-22, 2018.
“Potential of autofluorescent intracellular NADH and FAD to be used as biomarkers of the vulnerability of the atheromatous plaques”. Ottones F., Borowczyk C., Laroche-Traineau J., Brévier J., Bardet M. S, Louradour F., Gerbaud E. and Clofent-Sanchez G. Journée scientifique de la FR TecSAN, Bordeaux, May 15, 2018.
“Identification de fragments d’anticorps scFv spécifiques de populations macrophagiques colonisant les plaques d’athérome”. Boudigou M., Hemadou A., Jacobin-Valat MJ., Ottones F., Clofent-Sanchez G. Journée scientifique de la FR TecSAN, Bordeaux, June14, 2016.
14 communications orales dont 1 internationale
“The specific optical properties of foamy macrophages may be due to their specific metabolism and/or lipid handling”. Borowczyk C., Laroche-Traineau J., Grevelinger J., Brevier J., Garaude J., Marais, S. Gerbaud E., Jacobin-Valat M.-J., Clofent-Sanchez G., and Ottones F. Metaboday, Bordeaux, Janvier 20, 2022.
“Distinct functional phenotypes between major models of foamy macrophages: consequences and impact in the field of therapeutic research”. Brévier J., Gerbaud E., Borowczyk C., Grevelinger J., Laroche-Traineau J., Marais S., Jacobin-Valat M-J., Clofent-Sanchez G., and Ottones F. 4th Symposium of the Occitanie network on Monocytes-Macrophages (SoMM2021), Bordeaux, November 26, 2021.
“The specific optical properties of foamy macrophages may be due to their specific metabolism and/or lipid handling”. Borowczyk C., Laroche-Traineau J., Grevelinger J., Brevier J., Garaude J., Marais, S. Gerbaud E., Jacobin-Valat M.-J., Clofent-Sanchez G., and Ottones F. 4th Symposium of the Occitanie network on Monocytes-Macrophages (SoMM2021), Bordeaux, November 26, 2021.
Présentation de l’axe « Switch métabolique et fonctionnel » de l’équipe 2 pour le renouvellement de notre unité (CRMSB UMR5536). Ottones F. Evaluation HCERES (en visioconférence), Bordeaux, January 27, 2021.
“Two-Photon Excited Fluorescence (TPEF) may be useful to delimit macrophage subsets based on their metabolic activity and cellular responses in atherosclerotic plaques”. Borowczyk C., Laroche-Traineau J., Brevier J., Marais S., Gerbaud E., Clofent-Sanchez G. and Ottones F. Selected for a e-poster oral communication at the 88th EAS virtual Congress, October 4-7, 2020).
“Arguments and discussion around the repolarization of macrophages induced by therapeutic antibodies”. Ottones F. Journal Club du CMB (Club Macrophage de Bordeaux), March 13, 2020.
“Evaluating cell metabolism through autofluorescence imaging of NADH and FAD by 2-Photon microscopy in the context of Atherosclerosis”, Borowczyk C., Laroche-Traineau J., Brevier J., Marais S., Gerbaud E., Clofent-Sanchez G. and Ottones F. MetaboDay, Bordeaux, January 30, 2020.
“Macrophages in atherosclerosis. On the way to new macrophage-targeted strategies for the théranostic of atherosclerosis”, Ottones F. CMB, Bordeaux, June 28, 2019.
“Caractérisation phénotypique et métabolique de macrophages spumeux… vers une nouvelle façon de « voir » les macrophages de la plaque d’athérome”. Ottones F. Présentations mensuelles du CRMSB. Bordeaux, January 8, 2019.
“MEMIM: Multiphoton Endomicroscopy of Metabolic Imaging of Macrophages in atherosclerosis”. Ottones F. Présentation en tant que projets Lauréats de l’AAP2017, Assemblée Générale de TRAIL, March 2, 2018.
“Targeting of Macrophages in atherosclerosis using human scFv antibody fragments”. Ottones F. Webinar presentation for the laboratory of Zahi FAYAD, Bordeaux, February 7, 2017.
“Targeting of macrophages in atherosclerosis using human scFv antibody fragments”. Ottones F. Présentation pour la compagnie LFB, groupe pharmaceutique spécialiste des médicaments issus du vivant. Paris, June 24, 2016.
“Identification de fragments d’anticorps ScFv spécifiques de populations macrophagiques colonisant les plaques d’athérome”. Boudigou M., Hemadou A., Jacobin-Valat MJ, Laroche-Traineau J., Ottones F., Clofent-Sanchez G. Poster sélectionné pour présentation orale. Journée scientifique de la FR TecSAN, Bordeaux, June 14, 2016. (Félicitations orales du jury pour la qualité de sa prestation à défaut de prix car seuls les doctorants étaient éligibles).
“Etude du macrophage dans la plaque d’athérome. Idée : exploiter la capacité de polarisation du macrophage dans le théranostic de l’athérosclérose”. Ottones F. Réunion Bilan de l’ANR « ATHERANOS », Bordeaux, March 2-3, 2016.
